BIOMARKER:

ABCB1 overexpression

Contact us to learn more about our Premium Content:

News alerts, weekly reports and conference planners

Entrez ID:

Related biomarkers:

‹

›

ABCB1 overexpression	Squamous Cell Carcinoma of Head and Neck	ABCB1 overexpression	Squamous Cell Carcinoma of Head and Neck	cisplatin + 5-fluorouracil Sensitive: C3 – Early Trials cisplatin + 5-fluorouracil Sensitive : C3	cisplatin + 5-fluorouracil Sensitive: C3 – Early Trials cisplatin + 5-fluorouracil Sensitive : C3
ABCB1 overexpression	Head and Neck Cancer	ABCB1 overexpression	Head and Neck Cancer	paclitaxel Resistant: C3 – Early Trials paclitaxel Resistant : C3	paclitaxel Resistant: C3 – Early Trials paclitaxel Resistant : C3
ABCB1 overexpression	Non Small Cell Lung Cancer	ABCB1 overexpression	Non Small Cell Lung Cancer	paclitaxel Resistant: D – Preclinical paclitaxel Resistant : D	paclitaxel Resistant: D – Preclinical paclitaxel Resistant : D
ABCB1 overexpression	Multiple Myeloma	ABCB1 overexpression	Multiple Myeloma	carfilzomib Resistant: D – Preclinical carfilzomib Resistant : D	carfilzomib Resistant: D – Preclinical carfilzomib Resistant : D
ABCB1 overexpression	Colorectal Cancer	ABCB1 overexpression	Colorectal Cancer	PF-05212384 Resistant: D – Preclinical PF-05212384 Resistant : D	PF-05212384 Resistant: D – Preclinical PF-05212384 Resistant : D
ABCB1 overexpression	Ovarian Cancer	ABCB1 overexpression	Ovarian Cancer	lapatinib + poziotinib Sensitive: D – Preclinical lapatinib + poziotinib Sensitive : D	lapatinib + poziotinib Sensitive: D – Preclinical lapatinib + poziotinib Sensitive : D